Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00391456 · ClinicalTrials.gov registry record · NA

Animal-Assisted Therapy for Hospitalized Heart Failure Patients

A NA study of Heart Failure, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT00391456: Completed NA study of Heart Failure, sponsored by University of California, Los Angeles.

NCT00391456 is a NA study of Heart Failure that has completed, run by University of California, Los Angeles. The registered enrollment target is 76 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00391456, a NA study of Heart Failure, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

Effects of complementary therapies on heart failure, a leading cause of hospitalization, are unknown. Animal-assisted therapy improves physiological and psychosocial variables in healthy and hypertensive subjects. The purpose of this study was to determine whether a 12-minute hospital visit with a therapy dog improves hemodynamics, lowers neurohormone levels, and decreases state anxiety in patients hospitalized with heart failure.

Conditions Studied

Interventions

  • BEHAVIORAL Animal-assisted Therapy

Study Locations (1)

California

  • UCLA Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2001-11
Est. Completion 2004-07
Phase NA

What the finished NCT00391456 record still lists

NCT00391456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Animal-assisted Therapy is the first listed.

NCT00391456 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00391456 about?

NCT00391456 is a clinical study titled "Animal-Assisted Therapy for Hospitalized Heart Failure Patients". Effects of complementary therapies on heart failure, a leading cause of hospitalization, are unknown. Animal-assisted therapy improves physiological and psychosocial variables in healthy and hypertensive subjects. The purpose of this study was to determine whether a 12-minute hospital visit with a ...

What is the current status of trial NCT00391456?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2001-11. Estimated completion is 2004-07.

What conditions does trial NCT00391456 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT00391456?

The interventions under investigation include: Animal-assisted Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00391456?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00391456 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00391456's enrollment target sits among peer trials

76 232nd of 397 higher than 166 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00391456, the US trial registry maintained by the National Library of Medicine. NCT00391456 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.